ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2/STAT3 pathway.

Wei Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.